Knowing the fact that mitochondria are an essential part of the extrinsic and intrinsic pathways of apoptosis, we considered that mitochondrial estrogen receptors might contribute to endocrine therapy resistance and therefore have a potential of being prominent targets in breast cancer for the near future. This evidence concerns the gene ESR1 and breast carcinoma.